Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published January 2026 · Last reviewed May 2026
The Med Device Cyber Podcast · with Omar Khateeb · January 30, 2026 This episode of The Med Device Cyber Podcast features Omar Khateeb, host of The State of MedTech podcast. Khateeb discusses the current landscape of the MedTech industry, highlighting a shift from a period of consolidation with a few large strategics to the emergence of "mini-strategics" and increased M&A activity. This new environment offers more access to capital for startups, moving beyond traditional venture capital to include private investors and corporate investment arms. The conversation delves into the growing importance of cybersecurity in MedTech, particularly with the rise of AI-enabled and digitally integrated medical devices. Khateeb and the hosts emphasize that companies must de-risk cybersecurity from day one to attract strategic buyers and avoid regulatory issues like FDA warning letters. The discussion also touches on the proactive approach of the FDA in issuing guidance for AI in medical devices, and the concerns of healthcare delivery organizations and insurance companies regarding device security. The episode further explores the innovative business models needed in MedTech, advocating for a focus on market fit, reimbursement strategies, and regulatory compliance at the outset of product development. The hosts also touch on why entrepreneurship in MedTech may be less
Key Takeaways
- The MedTech industry is transitioning from consolidation by large strategics to a landscape with emerging “mini-strategics” and increased M&A activity.
- This shift provides greater access to capital for MedTech startups, moving beyond traditional venture capital to include private and corporate investments.
- Cybersecurity must be a foundational consideration from the initial stages of MedTech product development to attract strategic buyers and avoid regulatory complications like FDA warning letters.
- The FDA is proactively addressing the cybersecurity implications of AI-enabled medical devices, demonstrating an increased regulatory focus on this area.
- Innovative business models in MedTech need to prioritize market fit, effective reimbursement strategies, and adherence to regulatory classifications from inception.
- Despite perceived challenges in attracting talent and capital, the impact potential in MedTech is significant, requiring better industry marketing and a willingness for 'moonshot' innovation.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.